Menu

Comprehensive In Vitro Testing Services for Preclinical and Clinical Development

Explore our comprehensive suite of non-GLP in vitro assays designed to expedite your research. Need GLP-compliant solutions for IND-enabling studies? IBT has you covered.

  • Anti-viral Assays
  • Quantitative Testing Services
  • Functional Assays
  • Viability Assays
  • Stability Assays
  • Anti-bacterial Assays
  • Luminex Services
  • Flow Cytometry & Cell-based Assays
  • ELISA Testing
  • Cytotoxicity Testing

Optimize Your Drug Discovery with Precision In Vitro Assays

Leverage our expertise to identify the ideal assay for your test compound and its mechanism of action. Our comprehensive suite of in vitro assays, including neutralization, mechanism of action, immunoassay, functional assay, and analytical testing services, can evaluate the efficacy of drug candidates against a wide range of viral and bacterial targets.

Why Choose Us?

Our commitment to precision, reliability, and customer satisfaction makes us the trusted partner for research institutions, pharmaceutical companies, and diagnostic laboratories.

Partner with Us to Drive Innovation in Drug Discovery

In vitro Testing Services available at IBT:

Anti-viral AssaysAnti-bacterial AssaysBinding AssaysImmunoassaysOther ServicesViability AssaysGXP Testing Services
Cytopathic Effect Analysis (CPE)Minimum Inhibitory Concentration (MIC)ELISA Qualitative Testing Multiplex Cytokine AssaysmRNA & mRNA LNP Release TestingCell-Titer GLOGMP Western Blot Release Assay (Specificity)
Microneutralization Assay (MNT)Minimum Bactericidal Concentration (MBC)ELISA Quantitative Testing Multiplex Protein AssaysqPCR / RT PCR Testing Cytotoxicity Testing GMP A280 Measurements
Hemagglutination Inhibition Assay (HAI)Minimum Doubling Time (MDT)Sandwich ELISAsCustom Luminex AssaysDifferential Scanning FluorimetryFlow Cytometry GMP SDS-PAGE (Identity)
Plaque Reduction Neutralization Testing Assay (PRNT)Antimicrobial Susceptibility Testing Competitive ELISAsFlow CytometryCustom Protein ProductionLuminescent ATP AssayLAL Endotoxin Assay
Yield Reduction AssayBacterial Virulence AssaysDirect/Indirect ELISAsELISPOTCustom Antibody ProductionLuminex GLP/ GCLP Testing
TCID50 AssayToxin Neutralization AssayBiolayer InterferomeIFN-γ Release assaysProtein Stability Indicating AssaysPseudovirus Neutralization GLP/ GCLP Testing
Pseudovirus Neutralization Assays (PsVNA)Antimicrobial Synergy Testing (Checkerboard Assay)SizeExclusion Analysis HPLCNeutralization Assays GLP/ GCLP Testing
AntibodyDependent Enhancement Assays (ADE)Whole cell ELISA with bacterial supernatants

Deliverables & Data Reporting

Study ReportData SummaryMiscellaneous
Materials & MethodsResults & ConclusionsTech Transfer
Results & ConclusionData Tables & FiguresStandard Operating Procedure (SOP)
Data Tables & FiguresRaw Data FilesStandard for Exchange of Nonclinical Data (SEND)

Leading the Fight Against Emerging Infectious Diseases

IBT is at the forefront of research on emerging viral diseases and has established BSL-2/3 lab partnerships. We collaborate with our clients to develop innovative diagnostic tools, treatments, and vaccines to combat these and other global health threats.

VIRAL PANELBACTERIAL PANEL
Adenovirus (ADV)Staphylococcus aureusTable Data
Chikungunya Virus (CHIKV)Pseudomonas aeruginosa
Dengue Virus (Serotypes 1 to 4)Acinetobacter baumannii
Herpes Simplex Virus I & II (HSV)Moraxella catarrhalis
Ebola virus & Marburg virus Bacillus subtilis
Influenza A & B (INFV)Escherichia coli
Respiratory Syncytial Virus A & B (RSV)Enterobacter aerogenes
Zika Virus (ZIKV)Enterobacter cloacae

Need a Custom Solution?

Don’t see your strain of interest? With over 15 years of experience onboarding new strains and setting up assays, we can tailor our services to your specific needs. Contact us today!

    Search
    Generic filters